Polymorphic Skin Rash and Fatigue in a Patient with Diabetes Mellitus: A Quiz
DOI:
https://doi.org/10.2340/actadv.v106.adv-2026-0637Keywords:
glucagonoma, necrolytic migratory erythema, paraneoplastic syndromes, neuroendocrine tumors, pancreasDownloads
References
John AM, Schwartz RA. Glucagonoma syndrome: a review and update on treatment. J Eur Acad Dermatol Venereol 2016; 30: 2016–2022. DOI: https://doi.org/10.1111/jdv.13752
Toberer F, Hartschuh W, Wiedemeyer K. Glucagonoma-associated necrolytic migratory erythema: the broad spectrum of the clinical and histopathological findings and clues to the diagnosis. Am J Dermatopathol 2019; 41: e29–e32. DOI: https://doi.org/10.1097/DAD.0000000000001219
Li W, Yang X, Deng Y, Jiang Y, Xu G, Li E, et al. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma. Sci Rep 2022; 12: 9053. DOI: https://doi.org/10.1038/s41598-022-12882-2
Mastoraki A, Spyropoulos D, Stamatiadi S, Alexandraki K, Mylonakis A, Despotidis M, et al. Glucagonoma of the pancreas: diagnostic approach and therapeutic algorithm for a rare nosological entity. Ann Gastroenterol 2026; 39: 184–190. DOI: https://doi.org/10.20524/aog.2026.1037
Boujan N, Géraud C. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma. Lancet 2020; 395: 985. DOI: https://doi.org/10.1016/S0140-6736(20)30324-X
Cardoso Filho F de A, Feitosa RGF, Fechine COC, Matos CMM de, Cardoso AL, Cardoso DL. Glucagonoma syndrome associated with necrolytic migratory erythema. Rev Assoc Med Bras 2015; 61: 203–206. DOI: https://doi.org/10.1590/1806-9282.61.03.203
Alexander EK, Robinson M, Staniec M, Dluhy RG. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome. Clin Endocrinol (Oxf) 2002; 57: 827–831. DOI: https://doi.org/10.1046/j.1365-2265.2002.01660.x
He S, Zeng W, Geng S, Jia J. Glucagonoma syndrome with atypical necrolytic migratory erythema. Indian J Dermatol Venereol Leprol 2021; 87: 49–53. DOI: https://doi.org/10.4103/ijdvl.IJDVL_588_18
Perrier M, Brugel M, Gérard L, Goichot B, Lièvre A, Lepage C, et al. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network. Eur J Endocrinol 2023; 189: 575–583. DOI: https://doi.org/10.1093/ejendo/lvad157
Published
How to Cite
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
